Discovery of novel 2-(alkylmorpholin-4-yl)-6-(3-fluoropyridin-4-yl)-pyrimidin-4(3H)-ones as orally-active GSK-3β inhibitors for Alzheimer's disease. (Q55068127)
Jump to navigation
Jump to search
scientific article published on 13 January 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discovery of novel 2-(alkylmorpholin-4-yl)-6-(3-fluoropyridin-4-yl)-pyrimidin-4(3H)-ones as orally-active GSK-3β inhibitors for Alzheimer's disease. |
scientific article published on 13 January 2015 |
Statements
Discovery of novel 2-(alkylmorpholin-4-yl)-6-(3-fluoropyridin-4-yl)-pyrimidin-4(3H)-ones as orally-active GSK-3β inhibitors for Alzheimer's disease. (English)
1 reference
Kenji Fukunaga
1 reference
Daiki Sakai
1 reference
Kazutoshi Watanabe
1 reference
Kazuki Nakayama
1 reference
Toshiyuki Kohara
1 reference
Hiroshi Tanaka
1 reference
Shinji Sunada
1 reference
Mika Nabeno
1 reference
Masako Okamoto
1 reference
Ken-Ichi Saito
1 reference
Jun-ichi Eguchi
1 reference
Akiko Mori
1 reference
Shinji Tanaka
1 reference
Keiko Inazawa
1 reference
Takashi Horikawa
1 reference
13 January 2015
1 reference
25
1 reference
5
1 reference
1086-1091
1 reference